Table 5 Survival
| Â | nTMS | non-nTMS | p-value | |
|---|---|---|---|---|
All tumors | Overall survival (months) | 15.7 ± 10.9 | 11.9 ± 10.3 | 0.1310 |
3Â months survival rate (%) | 93.7 | 80.9 | 0.0298 | |
6Â months survival rate (%) | 88.5 | 62.7 | 0.0015 | |
9Â months survival rate (%) | 72.9 | 50.7 | 0.0167 | |
12Â months survival rate (%) | 58.7 | 40.3 | 0.0544 | |
WHO grade III | Overall survival (months) | 21.5 ± 9.0 | 7.2 ± 3.6 | 0.0322 |
3Â months survival rate (%) | 100.0 | 100.0 | 1.000 | |
6Â months survival rate (%) | 100.0 | 84.6 | 0.1410 | |
9Â months survival rate (%) | 91.7 | 76.9 | 0.3151 | |
12Â months survival rate (%) | 80.0 | 69.2 | 0.5598 | |
WHO grade IV | Overall survival (months) | 15.1 ± 11.1 | 12.4 ± 10.6 | 0.3196 |
3Â months survival rate (%) | 91.8 | 76.4 | 0.0332 | |
6Â months survival rate (%) | 84.6 | 57.4 | 0.0052 | |
9Â months survival rate (%) | 66.7 | 44.4 | 0.0384 | |
12Â months survival rate (%) | 52.8 | 33.3 | 0.0663 | |